Baidu
map

Nat Nanotechnol:一种植物病毒---豇豆病毒可有效对抗癌症

2015-12-24 王英 生物通

最近,美国凯斯西储大学和达特茅斯大学的研究人员报道称,一种常见的植物病毒的外壳,吸入肺部肿瘤或注射到卵巢癌、结肠癌或乳腺肿瘤中,不仅能引发小鼠免疫系统来消灭肿瘤,而且还提供了全身性保护来对抗肿瘤转移。科学家们测试了一个有着100年历史的构想——叫做“原位免疫”(in-situ vaccination)。这个想法是,在肿瘤中放某些东西,破坏可抑制免疫系统的环境,从而让自然防御系统来攻击恶性肿瘤。放入

一种植物病毒可有效对抗癌症
最近,美国凯斯西储大学和达特茅斯大学的研究人员报道称,一种常见的植物病毒的外壳,吸入肺部肿瘤或注射到卵巢癌结肠癌或乳腺肿瘤中,不仅能引发小鼠免疫系统来消灭肿瘤,而且还提供了全身性保护来对抗肿瘤转移。

科学家们测试了一个有着100年历史的构想——叫做“原位免疫”(in-situ vaccination)。这个想法是,在肿瘤中放某些东西,破坏可抑制免疫系统的环境,从而让自然防御系统来攻击恶性肿瘤。

放入肿瘤的那些东西——豇豆花叶病毒的硬质涂层,没有造成可察觉的副作用——这是用传统疗法和免疫疗法的一个常见问题。相关研究结果发表在最近的Nature Nanotechnology杂志上。

凯斯西储大学医学院生物医学工程助理教授Nicole Steinmetz指出:“基于豇豆病毒的纳米粒子,就像一个开关,可打开免疫系统来识别和对抗肿瘤——以及记住它。”

达特茅斯大学Geisel医学院微生物学与免疫学教授Steven Fiering指出:“这些粒子的效果是非常令人震惊的。它们容易制造,不需要在其表面或内部携带抗原、药物或其他免疫刺激剂。”

教授们与达特茅斯大学的分子和细胞生物学博士研究生Pat Lizotte、博士后Mee Rie Sheen、本科生Pakdee Rojanasopondist以及凯斯西储大学生物医学工程博士研究生Amy Wen一起,研究了这些纳米粒子。

再试一次

美国国家癌症研究所称,免疫系统检测和破坏异常细胞的能力,被认为可以预防许多癌症。但是当肿瘤开始发展时,它们可以关闭系统,从而允许肿瘤生长和扩散。

为了重新启动免疫防御系统,科学家们使用了肿瘤本身,就像疫苗中的抗原一样——即免疫系统产生抗体的靶标。

豇豆病毒的外壳——其传染的成分被剔除,可作为佐剂——可触发、并可能增强或延长抗原特异性免疫反应的一种物质。

过程和结果

研究人员首先打开小鼠的免疫系统,来攻击B16F10肺黑色素瘤或皮肤黑色素瘤,从而使老鼠无瘤。当处理的小鼠随后注射B16F10黑素瘤时(以重新挑战治愈小鼠),五只小鼠中有四只小鼠很快无瘤,另一只小鼠有生长缓慢的肿瘤。

研究证明,这些纳米粒子可有效对抗卵巢癌、乳腺癌和结肠癌模型。大部分的肿瘤从中心开始衰竭并坍塌。全身反应可阻止或攻击转移性疾病,这是癌症最致命的形式。Fiering说:“你获得了之前你甚至不知道的抗病益处。”

Fiering说:“因为我们所做的一切都是局部的,所以副作用是有限的,尽管免疫反应的力度和程度,但是未发现毒性。”

严重的副作用,如疲劳、疼痛、流感样症状等等,在化疗和放射疗法以及使用免疫刺激药物时是更为常见的。研究人员现在正试图了解病毒外壳是如何刺激免疫系统的。

Steinmetz说:“它不是细胞毒性的,没有RNA参与或用脂多糖作为佐剂,它不仅仅是一种刺激。我们看到了一种特定的免疫反应。”

Fiering说,不同于大多数的其他佐剂,病毒外壳可刺激中性粒细胞——白细胞的一种。其扮演了什么角色还是未知的。

研究人员正在寻求资助,研究这些外壳的物理性状,或是引起免疫反应的病毒特异性物质。他们也在寻求资助,以在免疫系统更接近于人类的动物模型中测试这种疗法。

研究人员认为,如果这种病毒外壳被继续证明是有效的,它最终可以与其他患者定制疗法组合使用。

原始出处:
P. H. Lizzotte et al. In situ vaccination with cowpea mosaic virus nanoparticles suppresses metastatic cancer.
Nature Nanotechnology
 
doi:10.1038/nnano.2015.292

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1880895, encodeId=cdb6188089560, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue Jun 28 12:59:00 CST 2016, time=2016-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1652146, encodeId=6f12165214695, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17245, encryptionId=13d01e24509, topicName=TEC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=852f24292001, createdName=shock_melon, createdTime=Thu Oct 13 05:59:00 CST 2016, time=2016-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1745186, encodeId=52611e4518603, content=<a href='/topic/show?id=bdc262694bb' target=_blank style='color:#2F92EE;'>#植物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62694, encryptionId=bdc262694bb, topicName=植物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Tue Sep 06 05:59:00 CST 2016, time=2016-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1701837, encodeId=dc641e01837dd, content=<a href='/topic/show?id=04b9e4784aa' target=_blank style='color:#2F92EE;'>#种植#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74784, encryptionId=04b9e4784aa, topicName=种植)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47e130405619, createdName=huangdf, createdTime=Sun Oct 30 18:59:00 CST 2016, time=2016-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47821, encodeId=03864e821e7, content=没大讲明白, beContent=null, objectType=article, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151022/IMG5628D6F14DBD16799.jpg, createdBy=ed8e1658452, createdName=靶细胞, createdTime=Fri Dec 25 23:56:00 CST 2015, time=2015-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47676, encodeId=de254e6765e, content=“研究人员正在寻求资助,”看到这句话,我就感觉,这玩意比较悬, beContent=null, objectType=article, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201205/e96b3d935daf4e258fba69d60175f0ab/b6d3ee4a3a414b8eafaf7c5e905937a2.jpg, createdBy=ad4b83208, createdName=vpssa, createdTime=Fri Dec 25 13:26:00 CST 2015, time=2015-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47645, encodeId=a2974e64542, content=还是没有突破, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Fri Dec 25 07:19:00 CST 2015, time=2015-12-25, status=1, ipAttribution=)]
    2016-06-28 liye789132251
  2. [GetPortalCommentsPageByObjectIdResponse(id=1880895, encodeId=cdb6188089560, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue Jun 28 12:59:00 CST 2016, time=2016-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1652146, encodeId=6f12165214695, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17245, encryptionId=13d01e24509, topicName=TEC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=852f24292001, createdName=shock_melon, createdTime=Thu Oct 13 05:59:00 CST 2016, time=2016-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1745186, encodeId=52611e4518603, content=<a href='/topic/show?id=bdc262694bb' target=_blank style='color:#2F92EE;'>#植物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62694, encryptionId=bdc262694bb, topicName=植物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Tue Sep 06 05:59:00 CST 2016, time=2016-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1701837, encodeId=dc641e01837dd, content=<a href='/topic/show?id=04b9e4784aa' target=_blank style='color:#2F92EE;'>#种植#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74784, encryptionId=04b9e4784aa, topicName=种植)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47e130405619, createdName=huangdf, createdTime=Sun Oct 30 18:59:00 CST 2016, time=2016-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47821, encodeId=03864e821e7, content=没大讲明白, beContent=null, objectType=article, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151022/IMG5628D6F14DBD16799.jpg, createdBy=ed8e1658452, createdName=靶细胞, createdTime=Fri Dec 25 23:56:00 CST 2015, time=2015-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47676, encodeId=de254e6765e, content=“研究人员正在寻求资助,”看到这句话,我就感觉,这玩意比较悬, beContent=null, objectType=article, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201205/e96b3d935daf4e258fba69d60175f0ab/b6d3ee4a3a414b8eafaf7c5e905937a2.jpg, createdBy=ad4b83208, createdName=vpssa, createdTime=Fri Dec 25 13:26:00 CST 2015, time=2015-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47645, encodeId=a2974e64542, content=还是没有突破, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Fri Dec 25 07:19:00 CST 2015, time=2015-12-25, status=1, ipAttribution=)]
    2016-10-13 shock_melon
  3. [GetPortalCommentsPageByObjectIdResponse(id=1880895, encodeId=cdb6188089560, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue Jun 28 12:59:00 CST 2016, time=2016-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1652146, encodeId=6f12165214695, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17245, encryptionId=13d01e24509, topicName=TEC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=852f24292001, createdName=shock_melon, createdTime=Thu Oct 13 05:59:00 CST 2016, time=2016-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1745186, encodeId=52611e4518603, content=<a href='/topic/show?id=bdc262694bb' target=_blank style='color:#2F92EE;'>#植物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62694, encryptionId=bdc262694bb, topicName=植物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Tue Sep 06 05:59:00 CST 2016, time=2016-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1701837, encodeId=dc641e01837dd, content=<a href='/topic/show?id=04b9e4784aa' target=_blank style='color:#2F92EE;'>#种植#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74784, encryptionId=04b9e4784aa, topicName=种植)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47e130405619, createdName=huangdf, createdTime=Sun Oct 30 18:59:00 CST 2016, time=2016-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47821, encodeId=03864e821e7, content=没大讲明白, beContent=null, objectType=article, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151022/IMG5628D6F14DBD16799.jpg, createdBy=ed8e1658452, createdName=靶细胞, createdTime=Fri Dec 25 23:56:00 CST 2015, time=2015-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47676, encodeId=de254e6765e, content=“研究人员正在寻求资助,”看到这句话,我就感觉,这玩意比较悬, beContent=null, objectType=article, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201205/e96b3d935daf4e258fba69d60175f0ab/b6d3ee4a3a414b8eafaf7c5e905937a2.jpg, createdBy=ad4b83208, createdName=vpssa, createdTime=Fri Dec 25 13:26:00 CST 2015, time=2015-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47645, encodeId=a2974e64542, content=还是没有突破, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Fri Dec 25 07:19:00 CST 2015, time=2015-12-25, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1880895, encodeId=cdb6188089560, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue Jun 28 12:59:00 CST 2016, time=2016-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1652146, encodeId=6f12165214695, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17245, encryptionId=13d01e24509, topicName=TEC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=852f24292001, createdName=shock_melon, createdTime=Thu Oct 13 05:59:00 CST 2016, time=2016-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1745186, encodeId=52611e4518603, content=<a href='/topic/show?id=bdc262694bb' target=_blank style='color:#2F92EE;'>#植物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62694, encryptionId=bdc262694bb, topicName=植物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Tue Sep 06 05:59:00 CST 2016, time=2016-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1701837, encodeId=dc641e01837dd, content=<a href='/topic/show?id=04b9e4784aa' target=_blank style='color:#2F92EE;'>#种植#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74784, encryptionId=04b9e4784aa, topicName=种植)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47e130405619, createdName=huangdf, createdTime=Sun Oct 30 18:59:00 CST 2016, time=2016-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47821, encodeId=03864e821e7, content=没大讲明白, beContent=null, objectType=article, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151022/IMG5628D6F14DBD16799.jpg, createdBy=ed8e1658452, createdName=靶细胞, createdTime=Fri Dec 25 23:56:00 CST 2015, time=2015-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47676, encodeId=de254e6765e, content=“研究人员正在寻求资助,”看到这句话,我就感觉,这玩意比较悬, beContent=null, objectType=article, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201205/e96b3d935daf4e258fba69d60175f0ab/b6d3ee4a3a414b8eafaf7c5e905937a2.jpg, createdBy=ad4b83208, createdName=vpssa, createdTime=Fri Dec 25 13:26:00 CST 2015, time=2015-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47645, encodeId=a2974e64542, content=还是没有突破, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Fri Dec 25 07:19:00 CST 2015, time=2015-12-25, status=1, ipAttribution=)]
    2016-10-30 huangdf
  5. [GetPortalCommentsPageByObjectIdResponse(id=1880895, encodeId=cdb6188089560, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue Jun 28 12:59:00 CST 2016, time=2016-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1652146, encodeId=6f12165214695, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17245, encryptionId=13d01e24509, topicName=TEC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=852f24292001, createdName=shock_melon, createdTime=Thu Oct 13 05:59:00 CST 2016, time=2016-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1745186, encodeId=52611e4518603, content=<a href='/topic/show?id=bdc262694bb' target=_blank style='color:#2F92EE;'>#植物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62694, encryptionId=bdc262694bb, topicName=植物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Tue Sep 06 05:59:00 CST 2016, time=2016-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1701837, encodeId=dc641e01837dd, content=<a href='/topic/show?id=04b9e4784aa' target=_blank style='color:#2F92EE;'>#种植#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74784, encryptionId=04b9e4784aa, topicName=种植)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47e130405619, createdName=huangdf, createdTime=Sun Oct 30 18:59:00 CST 2016, time=2016-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47821, encodeId=03864e821e7, content=没大讲明白, beContent=null, objectType=article, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151022/IMG5628D6F14DBD16799.jpg, createdBy=ed8e1658452, createdName=靶细胞, createdTime=Fri Dec 25 23:56:00 CST 2015, time=2015-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47676, encodeId=de254e6765e, content=“研究人员正在寻求资助,”看到这句话,我就感觉,这玩意比较悬, beContent=null, objectType=article, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201205/e96b3d935daf4e258fba69d60175f0ab/b6d3ee4a3a414b8eafaf7c5e905937a2.jpg, createdBy=ad4b83208, createdName=vpssa, createdTime=Fri Dec 25 13:26:00 CST 2015, time=2015-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47645, encodeId=a2974e64542, content=还是没有突破, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Fri Dec 25 07:19:00 CST 2015, time=2015-12-25, status=1, ipAttribution=)]
    2015-12-25 靶细胞

    没大讲明白

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1880895, encodeId=cdb6188089560, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue Jun 28 12:59:00 CST 2016, time=2016-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1652146, encodeId=6f12165214695, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17245, encryptionId=13d01e24509, topicName=TEC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=852f24292001, createdName=shock_melon, createdTime=Thu Oct 13 05:59:00 CST 2016, time=2016-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1745186, encodeId=52611e4518603, content=<a href='/topic/show?id=bdc262694bb' target=_blank style='color:#2F92EE;'>#植物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62694, encryptionId=bdc262694bb, topicName=植物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Tue Sep 06 05:59:00 CST 2016, time=2016-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1701837, encodeId=dc641e01837dd, content=<a href='/topic/show?id=04b9e4784aa' target=_blank style='color:#2F92EE;'>#种植#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74784, encryptionId=04b9e4784aa, topicName=种植)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47e130405619, createdName=huangdf, createdTime=Sun Oct 30 18:59:00 CST 2016, time=2016-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47821, encodeId=03864e821e7, content=没大讲明白, beContent=null, objectType=article, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151022/IMG5628D6F14DBD16799.jpg, createdBy=ed8e1658452, createdName=靶细胞, createdTime=Fri Dec 25 23:56:00 CST 2015, time=2015-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47676, encodeId=de254e6765e, content=“研究人员正在寻求资助,”看到这句话,我就感觉,这玩意比较悬, beContent=null, objectType=article, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201205/e96b3d935daf4e258fba69d60175f0ab/b6d3ee4a3a414b8eafaf7c5e905937a2.jpg, createdBy=ad4b83208, createdName=vpssa, createdTime=Fri Dec 25 13:26:00 CST 2015, time=2015-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47645, encodeId=a2974e64542, content=还是没有突破, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Fri Dec 25 07:19:00 CST 2015, time=2015-12-25, status=1, ipAttribution=)]
    2015-12-25 vpssa

    “研究人员正在寻求资助,”看到这句话,我就感觉,这玩意比较悬

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1880895, encodeId=cdb6188089560, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue Jun 28 12:59:00 CST 2016, time=2016-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1652146, encodeId=6f12165214695, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17245, encryptionId=13d01e24509, topicName=TEC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=852f24292001, createdName=shock_melon, createdTime=Thu Oct 13 05:59:00 CST 2016, time=2016-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1745186, encodeId=52611e4518603, content=<a href='/topic/show?id=bdc262694bb' target=_blank style='color:#2F92EE;'>#植物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62694, encryptionId=bdc262694bb, topicName=植物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Tue Sep 06 05:59:00 CST 2016, time=2016-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1701837, encodeId=dc641e01837dd, content=<a href='/topic/show?id=04b9e4784aa' target=_blank style='color:#2F92EE;'>#种植#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74784, encryptionId=04b9e4784aa, topicName=种植)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47e130405619, createdName=huangdf, createdTime=Sun Oct 30 18:59:00 CST 2016, time=2016-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47821, encodeId=03864e821e7, content=没大讲明白, beContent=null, objectType=article, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151022/IMG5628D6F14DBD16799.jpg, createdBy=ed8e1658452, createdName=靶细胞, createdTime=Fri Dec 25 23:56:00 CST 2015, time=2015-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47676, encodeId=de254e6765e, content=“研究人员正在寻求资助,”看到这句话,我就感觉,这玩意比较悬, beContent=null, objectType=article, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201205/e96b3d935daf4e258fba69d60175f0ab/b6d3ee4a3a414b8eafaf7c5e905937a2.jpg, createdBy=ad4b83208, createdName=vpssa, createdTime=Fri Dec 25 13:26:00 CST 2015, time=2015-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47645, encodeId=a2974e64542, content=还是没有突破, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Fri Dec 25 07:19:00 CST 2015, time=2015-12-25, status=1, ipAttribution=)]
    2015-12-25 老段

    还是没有突破

    0

相关资讯

Lancet Oncol:儿童感染肠道病毒(手足口病等)可以减少白血病风险?!

研究者进行了一项研究,探究儿童肠道病毒感染后发生白血病的风险。该研究对NHIRD数据进行了全国性的回顾性队列研究。纳入了<18岁感染肠病毒的儿童,根据性别、年龄、城市化水平、父母职业、肠道病毒感染年份等按1:1对其匹配非肠病毒感染儿童。研究者仅仅纳入了含有完整信息、至少去过3次诊所诊断为肠病毒感染的儿童。按照第一次诊断为肠病毒感染时间作为起始随访时间。对所有研究对象进行随访,直到发生白血病或失访

科学家细数或引发下一次公共健康危机的致命病毒

西非埃博拉疫情暴发使专家考虑哪些疾病可能会导致下一次疫病危机。 图片来源:Waldo 在西非竭尽全力结束灾难性的埃博拉疫情之后,世卫组织(WHO)日前召集科学家在瑞士日内瓦共议哪些疾病可能引发下一场致命瘟疫。WHO希望以此避免尴尬的处境,因为去年当埃博拉疫情在西非暴发数月之后,该组织才着手建立治疗中心,并通过分辨和隔离接触者控制疫情。在此之前,全世界早应该为应对埃博拉疫

新药物或可长期有效抑制艾滋病毒

美国强生公司与其专门从事艾滋病(HIV)药物研发的合作伙伴 ViiV Healthcare在3日发布的研究结果中宣布,通过初步测试,每月注射两个或两个以上长期注射药物,可有效控制艾滋病病毒。报道表示,尽管该项研究有待进一步测试,但目前的研究意味着在治愈艾滋病这个一度几乎是致命疾病方面人类取得一个巨大进步。 据报道,通过测试,此前接受治疗的309例艾滋病患者,在每日服用药片后,其血液中的HIV

Heart:流感疫苗可以预防急性心肌梗死?

目前急性心肌梗死(AMI)是全球主要的致死致残性疾病。越来越来的观察性研究表明,流感病毒感染与AMI息息相关;对有冠状动脉疾病的患者,使用流感疫苗可以降低心血管事件发生风险。研究者进行了一项病例对照研究的荟萃分析,探究对于全人类流感的病毒感染或流感病毒疫苗和AMI发生的关系。该研究共纳入了16篇病例对照文章,8项研究是关于流感疫苗与AMI,有10项古娜与流感病毒感染和AMI的研究。研究数据显示,新

Gut:病毒性肝硬化患者对细菌感染不可大意

研究者进行了一项研究,探究病毒性肝硬化(代偿期)患者并发细菌感染的发生率和预后。该前瞻性研究在法国的35个中心进行。纳入了HCV或HBV感染的病毒性肝硬化(病检证实)患者,并且处于Child-Pugh A级,以前没有肝脏并发症。最终纳入了1672名患者 (HCV 1323, HBV 318, HCV-HBV 31),中位数随访43个月,有171名患者发生了234次细菌感染,5年累积发生率(CumI

Journal of Virology:人类基因组对支气管炎病毒的治疗

病毒在宿主中经过多种蛋白质的作用可进行复制和传播,但是这个作用过程目前不是很清楚。科学家们因此进行了一项研究,关于病毒复制中哪一种宿主因素起着关键的作用。 A*STAR分子和细胞生物学研究所的研究人员Frederic Bard称,体内有人类肺癌细胞的人会带有特殊的支气管炎病毒,可在细胞复制时引起发热。支气管炎病毒属于冠状病毒,会引起疾病严重威胁公众健康,如严重的急性呼吸系统综合症(SARS)

Baidu
map
Baidu
map
Baidu
map